Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · January 31, 2017

Cardiovascular Event Risk Assessment in Psoriasis Patients Treated With TNF-α Inhibitors Versus Methotrexate

Journal of the American Academy of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Academy of Dermatology
Cardiovascular Event Risk Assessment in Psoriasis Patients Treated With Tumor Necrosis Factor-α Inhibitors Versus Methotrexate
J Am Acad Dermatol 2016 Oct 26;[EPub Ahead of Print], JJ Wu, A Guérin, M Sundaram, K Dea, M Cloutier, P Mulani

Further Reading